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Preparation of the starting material (RS)-1 
Racemic N-(2-methylbenzylidene)-phenylglycine amide ((RS)-1) was prepared from commercially 
available (RS)-phenylglycine ((RS)-Phg). 
Step 1: A suspension of 1 mol of (RS)-Phg, originally produced commercially by DSM Pharmaceutical 
Products from benzaldehyde by means of a Strecker reaction with NH3/HCN and subsequent acidic 
hydrolysis*, in 1 L of MeOH was cooled to 0°C and 1.2 mol of SOCl2 was slowly added over a period 
of several hours in order to keep the temperature below 20°C. The clear solution was stirred for 18 h at 
ambient temperature and subsequently refluxed for 1 h in order to remove the SO2. The volume was 
then reduced to 350 mL by evaporation under reduced pressure and 1.5 L of MTBE was added to 
crystallize the (RS)-Phg methyl ester HCl salt. The crystals were filtered and dried under reduced 
pressure and were used as such in the next step. 
* Note: Phg forms a very stable racemic compound and has a eutectic composition with 97% ee. 
Step 2: The crystals described above were added in portions to a stirred solution of 750 mL of 
concentrated ammonia. During the addition (RS)-Phg amide started to precipitate and stirring was 
continued for a few hours until all the methyl ester was converted (tested by TLC on silica, eluent: 
CHCl3, MeOH, conc. ammonia 60:45:20). The racemic amide was filtered, washed with cold water 
(note, solubility 5 wt%) and dried. Overall yield approximately 80%. 
Step 3: To a stirred solution of 68.6 g of (RS)-Phg amide in a mixture of 150 mL of water and 300 mL 
of MeOH at ambient temperature was added 55.9 g of 2-methylbenzadehyde over a period of 1 hour 
(after addition of 20% of the aldehyde crystallisation usually starts spontaneously; if not it is better to 
add racemic seed crystals for a controlled crystallisation). The thick suspension was stirred for 20 h at 
ambient temperature and then filtered. The crystals were washed with 100 mL of MeOH/water 2:1 and 
200 ml of MTBE, dried under reduced pressure, thus yielding 110 g (95%) of NMR and HPLC pure 
(RS)-1 as colorless needles. M.p. 153°C. 1H NMR (200 MHz, CDCl3) δ 8.61 (s, 1H), 7.95 (dd, 1H, J=8.0 
  
S-3 
and 1.7 Hz), 7.19-7.53 (m, 8H), 7.01 (br s, 1H), 5.91 (br s, 1H), 4.99 (s, 1H) and 2.52 (s, 3H). 13C NMR 
(50 MHz, CDCl3) δ 171.61 (s), 160.26 (d), 139.42 (s), 137.00 (s), 132.44 (s), 129.80 (d), 129.67 (d), 
127.23 (d), 126.73 (d) 126.26 (d), 124.95 (d), 76.36 (d) and 17.94 (q). Calculated for C16H16N2O: C, 
75.16%; H, 6.39%; N, 11.10%. Found: C, 75.78%; H, 6.37%; N, 11.09%. MS(CI): m/z = 253 (M+1).  
(RS)-1 may be further purified by several recrystallisations from MeOH (2.5 L for 100 g, crystallisation 
yield 75-80%). However, this had no effects on the deracemization experiments described in this paper.  
 
Care should be taken not to heat the methanolic solution of (RS)-1 for longer period of time, in order to 
prevent formation of the cyclization product 2-(2-methylphenyl)-5-phenyl-imidazolidin-4-one (racemic 
1:1 diastereomeric mixture). 
 
Analogously to the method above also (R)-1 and (S)-1 were prepared from commercially available (R)-
phenylglycine amide and (S)-phenylglycine, respectively. M.p. 180°C. (R)-enantiomer; [α]25D -29.9 (c = 
0.5, MeOH). 
 
The virgin deracemization experiments 
In 100 mL round bottom flask with an oval PTFE-coated magnetic stirring bar (L 20mm, Ø 10mm) 
were weighed in  4.0g of (RS)-1, 36g of MeOH (PA quality) and 10g Ø 2-2.5 mm glass pearls (Aldrich). 
The flask was sealed and stirred for 24 hours at 1250 rpm magnetic stirrer to equilibrate the solvent and 
solute. Furthermore, the possible memory effect of the crystal size distribution is overcome by grinding 
all the crystals. From this suspension the t = 0 sample was taken. To the suspension was then added 200 
mg (200 µL) of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU)  (5 mol%) and stirring was started at 1200-
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1300 rpm. Samples were taken every 3 days. The chiral purity was measured using chiral HPLC as 
described below, and confirmed by polarimetry.  
Further analysis was performed using 1H-NMR, DSC and XRPD.  
After prolonged stirring in the solid 1 samples 2-(2-methylphenyl)-5-phenyl-imidazolidin-4-one can be 
detected as a racemic 9:1 diastereomeric side-product. Both diastereomers of the side-product are 
racemic within the HPLC detection limits (fide infra). 
 
Experiments with initial enantiomeric imbalances 
In the case MeOH was used as a solvent, a total of (R/S)-1 (c.a. 2.0 g), glass pearls (5 g) and MeOH (18 
g) were placed in a 100 ml round bottom flask with a magnetic stirring bar. The mixture was stirred 
overnight at room temperature in order to crush solid particle size. To the suspension, DBU (100 µL, 5 
mol%) was added and stirring was started at 1000 rpm. The flask was manually shaken daily and 
samples were taken before addition of DBU (t = 0) and 7, 14, 21 and 35 days after the addition of DBU. 
Four experiments with 2% ee, 5% ee, 7% ee and 10% ee (S) were carried out in MeOH (Fig. 1). When 
using MeCN as a solvent, (RS)-1 + appropriate amounts of (R)-1 or (S)-1 (total c.a. 4.0 g), glass pearls 
(10 g) and MeCN (36 g) were placed in a 100 mL round bottom flask. After stirring overnight (1250 
rpm), the t = 0 sample was taken and DBU was added (200 µL,5 mol%). Samples were taken every 3 
days. Further analysis was performed as described for the virgin experiments. No side product formation 




Experiments with (R)- and (S)-phenylglycine as additive 
In a 100 mL B24 round bottom flask with magnetic stirring bar were weighed in 10 gram of glass 
pearls, 4.0 g of (RS)-1 and 36 g of MeOH or MeCN. The mixture was stirred at 1250 rpm at room 
temperature for 15 min. Thereafter, 2.5-200 mg of (R)-Phg was added using a weighing paper. Stirring 
was continued for 1-24 h to reach equilibrium. From this suspension the t = 0 sample was taken. To the 
suspension was then added 200 mg (200 µL) of DBU (5 mol%) and stirring was continued at 1200-1300 
rpm. For high concentrations of Phg additional DBU has to be added to overcome the effect of reduced 
basicity as a result of salt formation between the DBU and Phg. After addition of DBU the pH should be 
approximately 12 to ensure that racemization occurs. 
 
Sampling 
For sampling, 2-3 mL of the slurry was taken with a pipette and filtered on a P3 or P4 glass filter (Ø 10 
mm). The residue was washed with 1 mL of MeOH or MeCN, respectively, and 2 mL of MTBE to 
remove mother liquid and DBU, and dried overnight in a vacuum stove overnight at 40 ºC. 
 
Dissolution enrichment experiments 
Small enantioimbalances can already be amplified to single chirality. Although the starting material is 
prepared from (RS)-Phg, which is a very stable racemic compound, we checked the enantiopurity by 
dissolution.  Conglomerates which are enriched in one enantiomer enrich in the solid phase upon 
dissolution. To check if 1 was racemic, ca. 0.4 g 1 was partially dissolved in 12 ml MeCN. After stirring 
the suspension overnight, the solid material was collected on a P3 glass filter and dried in a vacuum 
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stove. Chiral HPLC analysis and polarimetry showed no chiral enrichment, confirming that the starting 
material was racemic within the detection limits.     
Determination of the ee by chiral HPLC analysis of the solids samples 
Sample preparation 0.5 mg solid in 1.5 mL eluent, injection volume 20µL, HPLC column Chiralcel-OJ 
(250x4.6 mm ID), eluent n-hexane/2-propanol 80/20 v/v%, flow 1mL/min, r.t., detection λ=254 nm. 
Retention times (S)-1 11.4 min, (R)-1 17.4 min, (2R*,5R)-2-(2-methylphenyl)-5-phenyl-imidazolidin-4-
one (cyclic side-product) 8.8 min, (2S*,5S)-side-product 9.8 min, (2S*,5R)-side-product 11.2 min, 
(2R*,5S)-side-product 11.9 min. The response factor of 1 is 25 times higher than of the cyclic side-




Control of  ee determination 
As a check of the ee determination by the chiral HPLC method described above, an independent ee 
determined has been performed on some of the samples.  
Therefore 50-60 mg of enantiomerically enriched 1, isolated from various deracemization experiments, 
was dissolved in 3 mL of 0.25M HCl solution. The solution was extracted two times with 3 mL of 
CHCl3. The remaining aqueous solution of phenylglycine amide HCl salt was used as such for the ee 
determination by the following HPLC method. Column; Crownether Cr(+) 150 x 4.6 mm ID, eluent; 
aqueous HClO4 pH=1.2 / Methanol 90/10 v/v%, flow; 1 mL/min, temperature; 25 °C, detection: UV 220 
nm, detection limit: 0.01 area%. 
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The results of this control ee determination were in agreement with the values obtained by the standard 
HPLC method described above. 
 
Fig. 1. Attrition-enhanced evolution of solid-phase ee for 1 in MeOH from initial ee values as shown. 
Lines are provided as a guide to the eye. 
 
